Secretory IgA and course of COVID-19 in patients receiving a bacteria-based immunostimulant agent in addition to background therapy.
Kostinov M, Svitich O, Chuchalin A, Osiptsov V, Khromova E, Abramova N, Tatevosov V, Vlasenko A, Gainitdinova V, Pakhomov D, Mashilov K, Ospelnikova T, Mihajlova N, Polishchuk V, Kurbatova E, Kostinova A.
Kostinov M, et al.
Sci Rep. 2024 May 15;14(1):11101. doi: 10.1038/s41598-024-61341-7.
Sci Rep. 2024.
PMID: 38750098
Free PMC article.